Moneycontrol PRO
UPCOMING EVENT:Attend Traders Carnival Live. 3 days 12 sessions at Rs.1599/-, exclusive for Moneycontrol Pro subscribers. Register now!
you are here: HomeNewsTrendsHealth

Severe COVID-19 can lead to delirium, US study finds

The study, published in the journal BMJ Open, found that patients with delirium tended to be sicker, with more comorbidities like hypertension and diabetes, and appeared to have more severe COVID-related illness.

September 22, 2021 / 02:08 PM IST

A study of 150 patients hospitalised for COVID in the US at the beginning of the pandemic found that 73 per cent had delirium, a serious disturbance in mental state wherein a person is confused, agitated and unable to think clearly.

The study, published in the journal BMJ Open, found that patients with delirium tended to be sicker, with more comorbidities like hypertension and diabetes, and appeared to have more severe COVID-related illness.

"COVID is also associated with a number of other adverse outcomes that tend to prolong hospitalisation and make recovery difficult," said study author Phillip Vlisides, from the University of Michigan in the US.

The researchers used patient medical records and telephone surveys following hospital discharge for a group of patients hospitalised in the intensive care unit between March and May 2020.

They attempted to identify common threads amongst patients who developed delirium.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

The researchers noted that the disease itself can lead to reduced oxygen to the brain as well as the development of blood clots and stroke, resulting in cognitive impairment.

Inflammatory markers were greatly increased in patients with delirium. Confusion and agitation could be a result of inflammation of the brain, they said.

"Early on in the pandemic, we weren't performing standard delirium prevention protocols like we usually do," Vlisides said.

"A big reason for that is early on in the pandemic in the pre-vaccine era, we had limited personal protective equipment and were trying to limit COVID exposure and disease transmission," he added.

There was a correlation between the use of sedatives and delirium -- patients with delirium were sedated more often and frequently at higher doses.

"It is common to use IV sedatives in the ICU, particular for patients on a ventilator. However, from talking to nurses, we found that patients with severe COVID were inherently more delirious and agitated at baseline, perhaps prompting more sedative use,” said Vlisides.

The study also found that cognitive impairment can persist even after discharge.

Almost a third of patients did not have their delirium marked as resolved in their chart upon leaving the hospital and 40 per cent of these patients required skilled nursing care.

Almost a quarter of patients screened positive for delirium based on assessment by their caretaker. For some patients, these symptoms lasted for months.

This can make managing the recovery process after hospitalisation that much more difficult.

"Whatever creative ways we can implement in delirium prevention protocols is likely to be very helpful," Vlisides said.

"That includes consistent communication with family members, bringing in pictures and objects from home, and video visits if family cannot safely visit," he added.

The take-home message is that for patients hospitalised with severe COVID-19, cognitive impairment -- including depression and delirium -- is highly likely, he added.

"Overall, this study highlights another reason why getting vaccinated and preventing severe illness is so important. There can be long term neurological complications that perhaps we don't talk about as much as we should," Vlisides said.

Follow our full coverage of the coronavirus pandemic here.
PTI
first published: Sep 22, 2021 02:08 pm

stay updated

Get Daily News on your Browser
Sections
ISO 27001 - BSI Assurance Mark